821 related articles for article (PubMed ID: 25269698)
1. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.
Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698
[TBL] [Abstract][Full Text] [Related]
2. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization.
Thrift AP; Risch HA; Onstad L; Shaheen NJ; Casson AG; Bernstein L; Corley DA; Levine DM; Chow WH; Reid BJ; Romero Y; Hardie LJ; Liu G; Wu AH; Bird NC; Gammon MD; Ye W; Whiteman DC; Vaughan TL
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1667-76.e1. PubMed ID: 24530603
[TBL] [Abstract][Full Text] [Related]
3. Applying big GWAS data to clarify the role of obesity in Barrett's esophagus and esophageal adenocarcinoma.
Abrams JA; Chak A
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269700
[No Abstract] [Full Text] [Related]
4. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
[TBL] [Abstract][Full Text] [Related]
5. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
[TBL] [Abstract][Full Text] [Related]
6. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
[TBL] [Abstract][Full Text] [Related]
7. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.
Lanuti M; Liu G; Goodwin JM; Zhai R; Fuchs BC; Asomaning K; Su L; Nishioka NS; Tanabe KK; Christiani DC
Clin Cancer Res; 2008 May; 14(10):3216-22. PubMed ID: 18483390
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J
Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
Runge TM; Abrams JA; Shaheen NJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191
[TBL] [Abstract][Full Text] [Related]
10. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
11. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
[No Abstract] [Full Text] [Related]
12. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk.
Lee E; Stram DO; Ek WE; Onstad LE; MacGregor S; Gharahkhani P; Ye W; Lagergren J; Shaheen NJ; Murray LJ; Hardie LJ; Gammon MD; Chow WH; Risch HA; Corley DA; Levine DM; Whiteman DC; Bernstein L; Bird NC; Vaughan TL; Wu AH
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1801-3. PubMed ID: 26364162
[TBL] [Abstract][Full Text] [Related]
13. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma.
Menke V; Van Zoest KP; Moons LM; Pot RG; Siersema PD; Kuipers EJ; Kusters JG
Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106
[TBL] [Abstract][Full Text] [Related]
14. The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk.
Becker J; May A; Gerges C; Anders M; Schmidt C; Veits L; Noder T; Mayershofer R; Kreuser N; Manner H; Venerito M; Hofer JH; Lyros O; Ahlbrand CJ; Arras M; Hofer S; Heinrichs SK; Weise K; Hess T; Böhmer AC; Kosiol N; Kiesslich R; Izbicki JR; Hölscher AH; Bollschweiler E; Malfertheiner P; Lang H; Moehler M; Lorenz D; Ott K; Schmidt T; Nöthen MM; Hackelsberger A; Schumacher B; Pech O; Vashist Y; Vieth M; Weismüller J; Knapp M; Neuhaus H; Rösch T; Ell C; Gockel I; Schumacher J
Cancer Med; 2016 May; 5(5):888-91. PubMed ID: 26783083
[TBL] [Abstract][Full Text] [Related]
15. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.
Bull LM; White DL; Bray M; Nurgalieva Z; El-Serag HB
Dis Esophagus; 2009; 22(7):571-87. PubMed ID: 19222528
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma.
Snider EJ; Freedberg DE; Abrams JA
Dig Dis Sci; 2016 Aug; 61(8):2217-2225. PubMed ID: 27068172
[TBL] [Abstract][Full Text] [Related]
18. Role of obesity in Barrett's esophagus and cancer.
Murray L; Romero Y
Surg Oncol Clin N Am; 2009 Jul; 18(3):439-52. PubMed ID: 19500735
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
